Minimal derivatization of proteins

Chemistry: analytical and immunological testing – Biospecific ligand binding assay

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

436547, 436548, 436804, 436819, 436518, 435188, 530387, 530402, 530405, 530408, 424 11, G01N 33566

Patent

active

050595415

ABSTRACT:
There is disclosed a process for minimally derivatizing a targeting protein with a radionuclide such that the predominant species of derivatized targeting protein contains one radionuclide group as a single radiolabeled ligand, and whereby the binding characteristics of the targeting protein are minimally affected. There is further disclosed ligands that can chelate a metal radionuclide or bind a halogen radionuclide while providing a means for separating radiolabeled ligand from unradiolabeled ligand.

REFERENCES:
patent: 4305922 (1981-12-01), Rhodes
patent: 4331647 (1982-05-01), Goldenberg
patent: 4348376 (1982-09-01), Goldenberg
patent: 4361544 (1982-11-01), Goldenberg
patent: 4421735 (1983-12-01), Haber et al.
patent: 4444744 (1984-04-01), Goldenberg
patent: 4454106 (1984-06-01), Gansow et al.
patent: 4460559 (1984-07-01), Goldenberg
patent: 4460561 (1984-07-01), Goldenberg
patent: 4472509 (1984-09-01), Gansow et al.
patent: 4624846 (1986-11-01), Goldenberg
patent: 4668503 (1987-05-01), Hnatowich
patent: 4707352 (1987-11-01), Stavrianpoulos
patent: 4732864 (1988-03-01), Tolman
patent: 4732974 (1988-03-01), Nicolotti et al.
patent: 4741900 (1988-05-01), Alvarez et al.
patent: 4824986 (1989-04-01), Gansow
Chang et al., "Bifunctional Chelating Agents: Linking Radiometals to Biological Molecules," in Applications of Nuclear and Radiochemistry, Chapter 10, pp. 103-114.
Arano et al., "Synthesis and Evaluation of a New Bifunctional Chelating Agent for .sup.99m Tc Labeling Proteins: p-Carboxyethylphenylglyoxal-di(N-methylthio-semicarbazone)," Int. J. Nucl. Med. Biol. 12:425-30 (1986).
Eckelman et al., "Radiolabeling of Antibodies," Cancer Research 40:3036-3042 (1980).
Holland et al., "Studies on Commercially Available .sup.99 Mo/.sup.99m Radionuclide Generators--I. Comparison of Five Analytical Procedures for Determination of Total Technetium in Generator Eluants," App. Radiat. Isot. 37:165-171 (1986).
Holland et al., "Studies on Commercially Available .sup.99 Mo/.sup.99m Tc Radionuclide Generators--II. Operating Characteristic and Behavior of .sup.99 Mo/.sup.99m Tc Generators," Appl. Radiat. Isot. 37:173-180 (1986).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Minimal derivatization of proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Minimal derivatization of proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Minimal derivatization of proteins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-107955

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.